|
US5480772A
(en)
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
|
GB9517779D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
GB9517780D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
US7332648B2
(en)
|
1995-08-31 |
2008-02-19 |
Roslin Institute |
Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
|
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
|
US6077697A
(en)
*
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
|
AU4984697A
(en)
|
1996-10-11 |
1998-05-11 |
The Texas A & M University System |
Methods for the generation of primordial germ cells and transgenic animal species
|
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
|
US6235969B1
(en)
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
|
AU733681B2
(en)
|
1997-03-26 |
2001-05-24 |
Imperial College Innovations Ltd. |
Anticoagulant fusion protein anchored to cell membrane
|
|
IL133786A0
(en)
|
1997-07-03 |
2001-04-30 |
Univ Massachusetts |
Cloning using donor nuclei from non-serum starved, differentiated cells
|
|
US7923216B2
(en)
|
1997-08-14 |
2011-04-12 |
Institut Pasteur |
In vivo modulation of neuronal transport
|
|
US7923015B2
(en)
|
1997-08-14 |
2011-04-12 |
Institut Pasteur |
Methods for direct visualization of active synapses
|
|
JPH11127852A
(ja)
*
|
1997-10-28 |
1999-05-18 |
Snow Brand Milk Prod Co Ltd |
上皮細胞のｇ０期同調方法
|
|
US7351876B2
(en)
|
1998-01-16 |
2008-04-01 |
Agrobiogen Gmbh Biotechnologie |
Efficient nuclear transfer with primordial gametes
|
|
CA2318117A1
(en)
*
|
1998-01-16 |
1999-07-22 |
Agrobiogen Gmbh |
Efficient nuclear transfer using primordial germ cells
|
|
US6331659B1
(en)
*
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
|
JP2002511234A
(ja)
*
|
1998-03-16 |
2002-04-16 |
リレグ ピーティーワイ リミテッド |
ブタの核移植
|
|
AUPP294898A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Monash University |
Method of nuclear transfer
|
|
GB9808325D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Ltr Ciz Di Associazione Italia |
Source of nuclei for nuclear transfer
|
|
US6143564A
(en)
*
|
1998-07-07 |
2000-11-07 |
University Of Hawaii |
Use of the polar body chromosomes for the production of embryos and normal offspring
|
|
GB9820988D0
(en)
*
|
1998-09-25 |
1998-11-18 |
Biotech & Biolog Scien Res |
Screening method
|
|
WO2000022098A1
(en)
*
|
1998-10-12 |
2000-04-20 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
|
US6781030B1
(en)
*
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
|
EP1818397A1
(en)
*
|
1998-11-02 |
2007-08-15 |
Trustees Of Tufts College |
Methods for cloning animals
|
|
DE69940700D1
(de)
|
1998-11-19 |
2009-05-20 |
Pharming Intellectual Pty Bv |
Stabilisierung der milch transgener tieren
|
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
NZ550899A
(en)
*
|
1999-01-13 |
2008-07-31 |
Revivicor Inc |
Double nuclear transfer method and the production of a non human animal thereby
|
|
US7531715B1
(en)
*
|
1999-01-13 |
2009-05-12 |
Ppl Therapeutics (Scotland) |
Double nuclear transfer method and results thereof
|
|
EP2314700A1
(en)
|
1999-01-28 |
2011-04-27 |
Medical College of Georgia Research Institute, Inc |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
|
|
AU3382800A
(en)
|
1999-02-26 |
2000-09-14 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and uses thereof
|
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
|
WO2000051424A2
(en)
|
1999-03-04 |
2000-09-08 |
Ppl Therapeutics (Scotland) Ltd. |
Genetic modification of somatic cells and uses thereof
|
|
AU5553600A
(en)
|
1999-06-23 |
2001-01-31 |
Ppl Therapeutics (Scotland) Ltd |
Fusion proteins incorporating lysozyme
|
|
KR100368435B1
(ko)
*
|
1999-06-30 |
2003-01-24 |
황우석 |
체세포 복제동물의 생산을 위한 세포융합방법
|
|
KR100414043B1
(ko)
*
|
1999-06-30 |
2004-01-13 |
황우석 |
체세포 복제동물 및 그 생산방법
|
|
CA2334953A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Woo-Suk Hwang |
Method for producing human cloned embryos by employing inter-species nuclear transplantation technique
|
|
WO2001000795A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Hwang, Woo-Suk |
A method for producing cloned cows
|
|
CA2334954A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Woo-Suk Hwang |
A method for producing cloned tigers by employing inter-species nuclear transplantation technique
|
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
BR0013581A
(pt)
|
1999-08-23 |
2002-07-02 |
Dana Faber Cancer Inst Inc |
Pd-1, um receptor para b7-4, e usos para isto
|
|
EP2275559A3
(en)
|
1999-09-28 |
2011-03-23 |
Shire Human Genetic Therapies, Inc. |
Optimized messenger RNA
|
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
|
GB9927444D0
(en)
*
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
|
AU1777301A
(en)
*
|
1999-11-19 |
2001-05-30 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
KR100417566B1
(ko)
*
|
1999-11-19 |
2004-02-05 |
한국생명공학연구원 |
체세포 핵치환 복제수정란의 대량생산방법
|
|
EP1254210A4
(en)
|
2000-01-04 |
2003-07-02 |
Univ Connecticut |
METHOD FOR CLONING ANIMALS WITH TARGETED GENETIC CHANGES BY TRANSFER OF MALE OR FEMALE SOMATIC CELL CORES FROM LONG-TERM CULTURE INCLUDING ARTIFICIALLY INDUCED GENETIC CHANGES IN CORE RECEIVERS
|
|
US6635802B1
(en)
*
|
2000-01-10 |
2003-10-21 |
The Texas A&M University System |
Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
|
|
ES2272482T3
(es)
|
2000-01-20 |
2007-05-01 |
Diabcell Pty Limited |
Preparacion y xenotransplante de islotes porcinos.
|
|
AU2001236919A1
(en)
*
|
2000-02-09 |
2001-08-20 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses
|
|
AU2001245776A1
(en)
|
2000-03-15 |
2001-09-24 |
The University Of Georgia Research Foundation, Inc. |
Effective nuclear reprogramming in mammals
|
|
GB2360522A
(en)
|
2000-03-24 |
2001-09-26 |
Geron Corp |
A strategy for maintaining pregnancy
|
|
WO2001088096A2
(en)
*
|
2000-05-15 |
2001-11-22 |
Geron Corporation |
Ovine tissue for xenotransplantation
|
|
ATE439453T1
(de)
|
2000-06-05 |
2009-08-15 |
Genetics Inst Llc |
Zusammensetzungen, testsätze und methoden zur identifizierung und modulation von typ i diabetes
|
|
NZ522844A
(en)
|
2000-06-28 |
2005-02-25 |
Brigham & Womens Hospital |
PD-L2 molecules: novel PD-1 ligands and methods to identify compounds to modulate T cell activation
|
|
CA2634294A1
(en)
|
2000-08-03 |
2002-02-14 |
Therapeutic Human Polyclonals, Inc. |
Production of humanized antibodies in transgenic animals
|
|
AU2001284948A1
(en)
|
2000-08-15 |
2002-02-25 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
|
WO2002028164A2
(en)
*
|
2000-10-06 |
2002-04-11 |
Advanced Cell Technology, Inc. |
Cloning endangered and extinct species
|
|
HUP0303888A3
(en)
|
2000-11-28 |
2007-05-02 |
Wyeth Corp |
Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
|
JP2004526426A
(ja)
|
2000-11-28 |
2004-09-02 |
ワイス |
前立腺癌の診断および治療に有用なｋｉａａ核酸およびポリペプチドの発現分析
|
|
NZ526243A
(en)
*
|
2000-11-30 |
2006-02-24 |
Stemron Inc |
Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
|
|
CA2427322C
(en)
*
|
2000-12-22 |
2012-03-06 |
Aurox Llc |
Methods for cloning mammals using reprogrammed donor chromatin or donor cells
|
|
DE60044301D1
(de)
|
2000-12-22 |
2010-06-10 |
Agronomique Inst Nat Rech |
Positionsunabhängige und gewebespezifische Expression eines Transgens in der Milch eines Transgen-Tieres
|
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
|
US7491534B2
(en)
*
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
|
EP1860199B1
(en)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulating insulin receptor signaling
|
|
US20050177883A1
(en)
|
2001-01-30 |
2005-08-11 |
Rebholtz Paul C. |
Systems of transferring embryos and managing recipients
|
|
US20020132257A1
(en)
|
2001-01-31 |
2002-09-19 |
Tony Giordano |
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
|
|
JP2002262716A
(ja)
*
|
2001-03-07 |
2002-09-17 |
National Agricultural Research Organization |
株化細胞を用いて家畜個体を作出する方法
|
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US7265262B2
(en)
*
|
2001-03-21 |
2007-09-04 |
Roslin Institute (Edinburgh) |
Telomerizing nuclear donor cells and improving the efficiency on nuclear transfer
|
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
|
CA2442066C
(en)
|
2001-04-02 |
2005-11-01 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
|
EP2258842A1
(en)
|
2001-04-16 |
2010-12-08 |
Wyeth Holdings Corporation |
Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
|
EP1405068A4
(en)
*
|
2001-06-14 |
2007-09-26 |
Infigen Inc |
METHODS FOR CLONING MAMMALS WITH REMODELING FACTORS
|
|
WO2002102830A1
(en)
*
|
2001-06-15 |
2002-12-27 |
New Century Pharmaceuticals, Inc. |
Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
|
|
EP1900815B1
(en)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
|
CA2453183C
(en)
|
2001-07-12 |
2016-05-10 |
University Of Massachusetts |
In vivo production of small interfering rnas that mediate gene silencing
|
|
US20030211603A1
(en)
*
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
|
US20030224380A1
(en)
*
|
2001-10-25 |
2003-12-04 |
The General Hospital Corporation |
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
|
|
WO2003054143A2
(en)
*
|
2001-10-25 |
2003-07-03 |
Neurogenetics, Inc. |
Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
|
|
US20030170678A1
(en)
*
|
2001-10-25 |
2003-09-11 |
Neurogenetics, Inc. |
Genetic markers for Alzheimer's disease and methods using the same
|
|
AU2002364506A1
(en)
*
|
2001-11-09 |
2003-06-10 |
Trustees Of The University Of Pennsylvania |
Compositions for the derivation of germ cells from stem cells and methods of use thereof
|
|
WO2003042362A2
(en)
|
2001-11-09 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
|
|
AU2003235652A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Advanced Cell Technology, Inc. |
Cloning b and t lymphocytes
|
|
US20050170506A1
(en)
*
|
2002-01-16 |
2005-08-04 |
Primegen Biotech Llc |
Therapeutic reprogramming, hybrid stem cells and maturation
|
|
US20050090004A1
(en)
*
|
2003-01-16 |
2005-04-28 |
Sayre Chauncey B. |
Stem cell maturation for all tissue lines
|
|
US20030134422A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Sayre Chauncey Bigelow |
Stem cell maturation for all tissue lines
|
|
NZ535367A
(en)
*
|
2002-04-01 |
2008-01-31 |
Gtc Biotherapeutics Inc |
A method for selecting cell lines to be used for nuclear transfer in mammalian species
|
|
US20030217378A1
(en)
*
|
2002-04-05 |
2003-11-20 |
The University Of Georgia Research Foundation, Inc |
Cloning using rapidly matured oocytes
|
|
US7612250B2
(en)
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
|
EP2311980A1
(en)
|
2002-08-20 |
2011-04-20 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
US7122361B2
(en)
|
2002-10-10 |
2006-10-17 |
Wyeth |
Compositions employing a novel human kinase
|
|
US20040219563A1
(en)
*
|
2002-10-16 |
2004-11-04 |
Michael West |
Method using gene trapped stem cells for making pathways of stem cell differentiation and making and isolating differentiated cells
|
|
WO2004038026A2
(en)
|
2002-10-24 |
2004-05-06 |
Wyeth |
Calcineurin-like human phosphoesterase
|
|
AU2003290689A1
(en)
|
2002-11-08 |
2004-06-03 |
Kyowa Hakko Kirin Co., Ltd. |
Transgenic ungulates having reduced prion protein activity and uses thereof
|
|
US7611839B2
(en)
|
2002-11-21 |
2009-11-03 |
Wyeth |
Methods for diagnosing RCC and other solid tumors
|
|
US7297525B2
(en)
|
2002-11-27 |
2007-11-20 |
Wyeth |
Composition employing a novel human kinase
|
|
CA2886504C
(en)
|
2002-12-20 |
2019-01-08 |
Celera Corporation |
Wdr12 polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
|
EP1581812B1
(en)
|
2003-01-06 |
2008-07-16 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
|
ES2357116T5
(es)
|
2003-06-02 |
2021-09-03 |
Univ Massachusetts |
Métodos y composiciones para mejorar la eficacia y especificad de FNAi
|
|
AU2004248136B2
(en)
|
2003-06-02 |
2011-09-15 |
University Of Massachusetts |
Methods and compositions for controlling efficacy of RNA silencing
|
|
EP1654349A4
(en)
|
2003-08-14 |
2008-08-20 |
Exelixis Inc |
SULFS AS BETA-CATENIN PATH MODIFICATORS AND METHOD OF USE
|
|
CN102517381A
(zh)
|
2003-10-07 |
2012-06-27 |
千年药品公司 |
用于鉴定、评价、预防和治疗卵巢癌的核酸分子和蛋白质
|
|
EP1681988B1
(en)
|
2003-11-12 |
2015-04-08 |
The Children's Hospital Medical Center |
Method for diagnosis and treatment of pulmonary disorders
|
|
EP2386656B1
(en)
|
2003-11-26 |
2013-04-24 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
|
US7682828B2
(en)
|
2003-11-26 |
2010-03-23 |
Whitehead Institute For Biomedical Research |
Methods for reprogramming somatic cells
|
|
NZ550106A
(en)
*
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
|
CA2566256C
(en)
|
2004-05-07 |
2015-07-07 |
Applera Corporation |
Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
|
|
US8889639B2
(en)
|
2004-10-22 |
2014-11-18 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating PGC-1β to treat lipid-related diseases and disorders
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
|
WO2006099365A2
(en)
|
2005-03-11 |
2006-09-21 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
|
US20070011603A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Mikko Makela |
Method, system, device and software product for showing tooltips for page segments and generating content for the page segments
|
|
WO2007035213A2
(en)
|
2005-08-09 |
2007-03-29 |
Revivicor, Inc. |
Transgenic ungulates expressing ctla4-ig and uses thereof
|
|
JP2009507835A
(ja)
|
2005-09-09 |
2009-02-26 |
ジョンズ ホプキンス ユニバーシティ |
抗体、アゴニストおよびアンタゴニストを用いてニューリチン遺伝子をターゲティングすることによる調節性ｔ細胞およびｄｃの機能の操作
|
|
EP1926459B1
(en)
|
2005-09-19 |
2015-01-07 |
Histogenics Corporation |
Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
|
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
|
ATE536374T1
(de)
|
2006-09-01 |
2011-12-15 |
Therapeutic Human Polyclonals Inc |
Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren
|
|
EP2639318B1
(en)
|
2006-09-11 |
2015-04-08 |
Celera Corporation |
Genetic polymorphisms associated with Psoriasis, methods of detection and uses thereof
|
|
US7910303B2
(en)
|
2006-10-20 |
2011-03-22 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
|
KR101398220B1
(ko)
*
|
2006-10-30 |
2014-05-22 |
건국대학교 산학협력단 |
형질전환 배아 생성방법
|
|
WO2008085891A1
(en)
*
|
2007-01-05 |
2008-07-17 |
Worcester Polytechnic Institute |
Oocyte spindle-associated factors improve somatic cell cloning
|
|
CA3071055A1
(en)
|
2007-04-07 |
2008-10-16 |
Whitehead Institute For Biomedical Research |
Reprogramming of somatic cells
|
|
WO2008134522A1
(en)
*
|
2007-04-26 |
2008-11-06 |
President And Fellows Of Harvard College |
Deriving embryonic stem cells
|
|
US7972849B2
(en)
*
|
2007-05-17 |
2011-07-05 |
Oregon Health & Science University |
Primate pluripotent stem cells produced by somatic cell nuclear transfer
|
|
US20090111764A1
(en)
*
|
2007-10-25 |
2009-04-30 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Mitochondrial selection
|
|
WO2009055656A2
(en)
|
2007-10-26 |
2009-04-30 |
Centocor, Inc. |
Vectors, host cells, and methods of production and uses
|
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
|
KR100915397B1
(ko)
*
|
2008-02-22 |
2009-09-03 |
삼성전자주식회사 |
커버부재, 현상 카트리지 및 화상형성장치의 현상유닛
|
|
US20110071049A1
(en)
|
2008-03-12 |
2011-03-24 |
Nathaniel Heintz |
Methods and compositions for translational profiling and molecular phenotyping
|
|
US8288094B2
(en)
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
|
CN102725409B
(zh)
|
2008-06-13 |
2016-03-30 |
怀特黑德生物医学研究所 |
细胞编程和重编程
|
|
EP2733222A1
(en)
|
2008-07-09 |
2014-05-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
|
WO2010124200A2
(en)
|
2009-04-23 |
2010-10-28 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cancer
|
|
CA2759608A1
(en)
|
2009-04-24 |
2010-10-28 |
Oregon Health & Science University |
Methods for mitochondrial dna replacement in oocytes
|
|
EP2267153A1
(en)
|
2009-05-26 |
2010-12-29 |
Université Claude Bernard Lyon 1 |
Identification of netrin-1 receptor unc5c gene mutation in solid cancers
|
|
US9314005B2
(en)
|
2009-07-01 |
2016-04-19 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (SCID)
|
|
WO2011011678A2
(en)
|
2009-07-24 |
2011-01-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cytokine-cytokine signaling pathways
|
|
WO2011014721A2
(en)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pharmacokinetics
|
|
WO2011017518A2
(en)
|
2009-08-05 |
2011-02-10 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for drug metabolism
|
|
EP2467013A2
(en)
|
2009-08-20 |
2012-06-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pain
|
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
|
WO2011091134A2
(en)
|
2010-01-22 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
|
MX342017B
(es)
|
2010-03-26 |
2016-09-09 |
Dartmouth College |
Proteina mediadora de celula t regulatoria vista, agentes de enlace de vista y uso de los mismos.
|
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
|
JP2013541545A
(ja)
|
2010-10-22 |
2013-11-14 |
アグリ−ネオ・インコーポレーテッド |
成育中の植物の中及び表面の病原体を抑制するための過酢酸及び少なくとも１種のｓａｒ誘発剤の相乗活性
|
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
|
WO2012064090A2
(ko)
|
2010-11-08 |
2012-05-18 |
광주과학기술원 |
골격근-유래된 다능성 세포의 화학적 제조방법 및 이의 용도
|
|
ES2680636T3
(es)
|
2011-02-14 |
2018-09-10 |
Revivicor Inc. |
Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
|
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
|
HUE039793T2
(hu)
|
2011-05-16 |
2019-02-28 |
Univ Missouri |
Sertés reproduktív és légzési szindróma vírus rezisztens állatok
|
|
WO2013039996A1
(en)
|
2011-09-13 |
2013-03-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using fndc5
|
|
EP2814844B1
(en)
|
2012-02-15 |
2017-08-02 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
|
|
WO2013120554A1
(en)
|
2012-02-15 |
2013-08-22 |
Novo Nordisk A/S |
Antibodies that bind peptidoglycan recognition protein 1
|
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
|
FI3421486T3
(fi)
|
2012-06-22 |
2023-12-15 |
Dartmouth College |
Uusia vista-ig-rakenteita ja vista-ig:n käyttö autoimmuuni-, allergia- ja tulehdushäiriöiden hoitamiseksi
|
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
|
JP6368308B2
(ja)
|
2012-09-07 |
2018-08-01 |
トラスティーズ・オブ・ダートマス・カレッジ |
癌の診断および治療のためのｖｉｓｔａ調節剤
|
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
|
DK3712174T3
(da)
|
2013-12-24 |
2022-04-25 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
|
EP3154585B1
(en)
|
2014-06-11 |
2022-02-23 |
Kathy A. Green |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
|
BR112016030947A2
(pt)
|
2014-07-17 |
2017-10-24 |
Novo Nordisk As |
mutagênese dirigida ao local de anticorpos trem-1 para diminuição de viscosidade
|
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
|
MX2017007136A
(es)
|
2014-12-05 |
2017-12-04 |
Immunext Inc |
Identificacion de vsig8 como el receptor vista putativo y su uso para producir moduladores vista/vsig8.
|
|
EP3230320B1
(en)
|
2014-12-09 |
2020-10-07 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a humanized cluster of differentiation 274 gene
|
|
WO2016131133A1
(en)
|
2015-02-19 |
2016-08-25 |
Agri-Neo Inc. |
Composition of peracetic acid and at least one organic fungicide for the control of pathogens in and onto growing plants
|
|
CA2990360C
(en)
|
2015-06-24 |
2024-02-13 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
|
WO2017023570A1
(en)
|
2015-08-06 |
2017-02-09 |
The Curators Of The University Of Missouri |
Pathogen-resistant animals having modified cd163 genes
|
|
US20210106661A1
(en)
|
2015-10-29 |
2021-04-15 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
|
CN109069626A
(zh)
|
2016-02-12 |
2018-12-21 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
|
BR112018071153A2
(pt)
|
2016-04-15 |
2019-04-16 |
Immunext, Inc. |
anticorpos anti-vista humano e uso dos mesmos
|
|
JP2021519594A
(ja)
|
2018-04-02 |
2021-08-12 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
抗ｔｒｅｍ−１抗体およびその使用
|
|
US11160260B2
(en)
|
2018-04-17 |
2021-11-02 |
The Curators Of The University Of Missouri |
Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
|
|
EP4247151A1
(en)
|
2020-11-20 |
2023-09-27 |
Revivicor Inc. |
Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
|
|
CA3232376A1
(en)
|
2021-09-20 |
2023-03-23 |
Maria KOKKINAKI |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|
